TD Waterhouse Canada’s iShares US Pharmaceuticals ETF IHE Stock Holding History

TD Waterhouse Canada’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$85.5K	Hold	870	–	–	﹤0.01%	1282
2026 Q1	$76.2K	Hold	870	–	–	﹤0.01%	1261
2025 Q4	$73.7K	Buy	870 +225	+35%	+$18K	﹤0.01%	1107
2025 Q3	$48.3K	Hold	645	–	–	﹤0.01%	1199
2025 Q2	$42.7K	Hold	645	–	–	﹤0.01%	1154
2025 Q1	$43.6K	Hold	645	–	–	﹤0.01%	1115
2024 Q4	$42.3K	Sell	645 -8,315	-93%	-$572K	﹤0.01%	1121
2024 Q3	$630K	Sell	8,960 -532	-6%	-$37.1K	0.01%	573
2024 Q2	$633K	Sell	9,492 -703	-7%	-$46.1K	0.01%	558
2024 Q1	$817K	Buy	10,195 +145	+1%	+$9.59K	0.01%	536
2023 Q4	$757K	Sell	10,050 -678	-6%	-$39.8K	0.01%	463
2023 Q3	$766K	Sell	10,728 -30	-0.3%	-$1.84K	0.01%	445
2023 Q2	$766K	Sell	10,758 -23,385	-68%	-$1.39M	0.01%	454
2023 Q1	$2.16M	Buy	34,143 +21,873	+178%	+$1.32M	0.02%	309
2022 Q4	$922K	Sell	12,270 -189	-2%	-$11.4K	0.01%	418
2022 Q3	$860K	Sell	12,459 -144	-1%	-$8.87K	0.01%	426
2022 Q2	$951K	Buy	12,603 +96	+0.8%	+$6.09K	0.01%	421
2022 Q1	$938K	Sell	12,507 -753	-6%	-$47.7K	0.01%	466
2021 Q4	$998K	Buy	+13,260	New	+$841K	0.01%	482

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

TD Waterhouse Canada's IHE Position: Q2 2026 in Review

TD Waterhouse Canada held its iShares US Pharmaceuticals ETF (IHE) position steady in Q2 2026 at 870 shares worth $85.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1282.

TD Waterhouse Canada first reported a position in IHE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.16M in Q1 2023. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

TD Waterhouse Canada held 870 shares of iShares US Pharmaceuticals ETF worth $85.5K as of Q2 2026.
TD Waterhouse Canada left its iShares US Pharmaceuticals ETF share count unchanged in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1282 holding.
TD Waterhouse Canada first reported a position in iShares US Pharmaceuticals ETF in Q4 2021 and has held it in 19 quarters since.
TD Waterhouse Canada's iShares US Pharmaceuticals ETF position peaked at $2.16M in Q1 2023.
210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.